NCT01256476View on ClinicalTrials.gov

Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Primary DyslipidemiaMixed Dyslipidemia
Interventions
DRUG

pitavastatin

pitavastatin 4 mg once daily (QD)

DRUG

pravastatin

Pravastatin 40 mg once daily (QD)

Trial Locations (44)

Unknown

Huntsville

Muscle Shoals

Chandler

Goodyear

Phoenix

Beverly Hills

Los Angeles

Newport Beach

Colorado Springs

Clearwater

DeLand

Fort Luaderdale

Jacksonville

Miami

Oviedo

Pembroke Pines

Ponte Vedra

Addison

Chicago

Evansville

Indianapolis

Kansas City

Erlanger

Baltimore

Brockton

Edina

Las Vegas

Berlin

Rochester

Statesville

Cincinnati

Lyndhurst

Willoughby Hills

Tulsa

Eugene

Greer

Mt. Pleasant

Corpus Christi

Dallas

San Antonio

Salt Lake City

Norfolk

Richmond

Olympia

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY